Biomarker Study PM — Remote, Sponsor-Driven Trials

Syneos Health, Inc.; Alaska; Hybrid; USD 120,000 - 170,000; Full time

Job summary

Syneos Health seeks a Clinical Project Manager II with biomarker study operations expertise to join a sponsor-dedicated team. This remote-capable role leads biomarker and bioanalytical strategy from start to finish, coordinating cross-functional teams, vendors, and internal stakeholders to ensure high-quality data and trials.

You will work on global clinical programs (Phases 1–4), drive sample collection and analysis workflows, and ensure regulatory compliance and trial timelines while

Qualifications

• Significant experience managing biomarker studies and external vendors required.
• Strong understanding of biomarker and bioanalytical strategies in a clinical trial setting.
• Proven ability to coordinate complex sample collection and analysis workflows.
• Experience in a CRO or sponsor environment preferred.
• Familiarity with GCP and ICH guidelines.

Responsibilities

• Lead biomarker study operations across global trials.
• Oversee biomarker and bioanalytical activities with sponsor and collaborators.
• Serve as operational contact for all biomarker processes.
• Collaborate with cross-functional teams to integrate biomarker strategies.
• Plan and manage collection, tracking, and analysis of biological specimens.
• Advise study teams on sample management and logistics.

Skills

Biomarker study operations

Biomarker strategies

Cross-functional collaboration

Vendor management

Project management

GCP knowledge

ICH guidelines

Education

Bachelor's degree in Life Sciences/Medicine/Pharmacy/Nursing

Job description

Syneos Health seeks a Clinical Project Manager II with biomarker study operations expertise to join a sponsor-dedicated team. This remote-capable role leads biomarker and bioanalytical strategy from start to finish, coordinating cross-functional teams, vendors, and internal stakeholders to ensure high-quality data and trials.

You will work on global clinical programs (Phases 1–4), drive sample collection and analysis workflows, and ensure regulatory compliance and trial timelines while